Capital Guardian Trust’s Elevance Health ELV Stock Holding History

Capital Guardian Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$35.1M	Buy	124,479 +124,463	+777,894%	+$34M	0.47%	87
2019 Q1	$5K	Buy	+16	New	+$4.63K	﹤0.01%	293
2017 Q2	–	Sell	-498	Closed	-$82K	–	303
2017 Q1	$82K	Hold	498	–	–	﹤0.01%	400
2016 Q4	$72K	Sell	498 -54	-10%	-$7.23K	﹤0.01%	422
2016 Q3	$69K	Buy	552 +48	+10%	+$6.2K	﹤0.01%	409
2016 Q2	$66K	Hold	504	–	–	﹤0.01%	417
2016 Q1	$70K	Hold	504	–	–	﹤0.01%	405
2015 Q4	$70K	Sell	504 -117	-19%	-$16.1K	﹤0.01%	426
2015 Q3	$87K	Hold	621	–	–	﹤0.01%	391
2015 Q2	$102K	Hold	621	–	–	﹤0.01%	383
2015 Q1	$96K	Buy	+621	New	+$88.4K	﹤0.01%	387
2013 Q4	–	Sell	-300	Closed	-$25K	–	585
2013 Q3	$25K	Buy	+300	New	+$25.7K	﹤0.01%	389

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Guardian Trust's ELV Position: Q2 2019 in Review

Capital Guardian Trust increased its Elevance Health (ELV) stake by 777,894% in Q2 2019, buying an estimated $34M and bringing the position to 124,479 shares worth $35.1M. The position accounts for 0.47% of the portfolio, ranked #87.

Capital Guardian Trust first reported a position in ELV in Q3 2013 and has held it in 12 quarters since. 1,031 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

Capital Guardian Trust held 124,479 shares of Elevance Health worth $35.1M as of Q2 2019.
Capital Guardian Trust bought 124,463 Elevance Health shares in Q2 2019, an estimated $34M.
Elevance Health made up 0.47% of Capital Guardian Trust's portfolio in Q2 2019, its #87 holding.
Capital Guardian Trust first reported a position in Elevance Health in Q3 2013 and has held it in 12 quarters since.
1,031 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.